Literature DB >> 25962604

Expression of bone morphogenetic proteins 4, 6 and 7 is downregulated in kidney allografts with interstitial fibrosis and tubular atrophy.

Vesna Furic-Cunko1, Petar Kes, Marijana Coric, Tvrtko Hudolin, Zeljko Kastelan, Nikolina Basic-Jukic.   

Abstract

PURPOSE: Bone morphogenetic proteins (BMPs) are pleiotropic growth factors. This paper investigates the connection between the expression pattern of BMPs in kidney allograft tissue versus the cause of allograft dysfunction.
METHODS: The expression pattern of BMP2, BMP4, BMP6 and BMP7 in 50 kidney allografts obtained by transplant nephrectomy is investigated. Immunohistochemical staining is semiquantitatively evaluated for intensity to identify the expression pattern of BMPs in normal and allograft kidney tissues.
RESULTS: The expression of BMP4 is unique between different tubular cell types in grafts without signs of fibrosis. This effect is not found in specimens with high grades of interstitial fibrosis and tubular atrophy (IFTA). In samples with IFTA grades II and III, the BMP7 expression is reduced in a significant fraction of specimens relative to those without signs of IFTA. The expression pattern of BMP6 indicates that its activation may be triggered by the act of transplantation and subsequent reperfusion injury. The expression of BMP2 is strong in all types of tubular epithelial cells and does not differ between the compared allografts and control kidney specimens.
CONCLUSION: The intensity and expression pattern of BMP4, BMP6 and BMP7 in transplanted kidney tissue are found to be dependent upon the length of the transplanted period, the clinical indication for transplant nephrectomy and signs of IFTA in kidney tissue.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25962604     DOI: 10.1007/s11255-015-0993-1

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  22 in total

Review 1.  Strategies to improve long-term outcomes after renal transplantation.

Authors:  Manuel Pascual; Tom Theruvath; Tatsuo Kawai; Nina Tolkoff-Rubin; A Benedict Cosimi
Journal:  N Engl J Med       Date:  2002-02-21       Impact factor: 91.245

2.  Involvement of bone morphogenetic protein 2 in ossification of renal cell carcinoma.

Authors:  Mutsushi Yamasaki; Takeo Nomura; Hiromitsu Mimata; Yoshio Nomura
Journal:  J Urol       Date:  2004-08       Impact factor: 7.450

3.  Tailbud-derived mesenchyme promotes urinary tract segmentation via BMP4 signaling.

Authors:  Andrea Brenner-Anantharam; Cristina Cebrian; Richard Guillaume; Romulo Hurtado; Tung-Tien Sun; Doris Herzlinger
Journal:  Development       Date:  2007-04-18       Impact factor: 6.868

4.  Study of the association between the BMP4 gene and congenital anomalies of the kidney and urinary tract.

Authors:  Geisilaine Soares dos Reis; Ana Cristina Simões E Silva; Izabella Silva Freitas; Thiago Ramos Heilbuth; Luiz Armando de Marco; Eduardo Araújo Oliveira; Débora Marques Miranda
Journal:  J Pediatr (Rio J)       Date:  2013-10-13       Impact factor: 2.197

Review 5.  Bone morphogenetic proteins in development.

Authors:  B L Hogan
Journal:  Curr Opin Genet Dev       Date:  1996-08       Impact factor: 5.578

6.  Bone morphogenetic protein-7 expression is down-regulated in human clear cell renal carcinoma.

Authors:  Nikolina Basic-Jukic; Tvrtko Hudolin; Margareta Radic-Antolic; Marijana Coric; Renata Zadro; Zeljko Kastelan; Josip Pasini; Daniela Bandic-Pavlovic; Petar Kes
Journal:  J Nephrol       Date:  2011 Jan-Feb       Impact factor: 3.902

7.  Expression of bone morphogenetic protein-7, its receptors and Smad1/5/8 in normal human kidney and renal cell cancer.

Authors:  Dean Markić; Tanja Celić; Josip Spanjol; Antun Grsković; Dragica Bobinac; Zeljko Fuckar
Journal:  Coll Antropol       Date:  2010-04

8.  A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye.

Authors:  A T Dudley; K M Lyons; E J Robertson
Journal:  Genes Dev       Date:  1995-11-15       Impact factor: 11.361

9.  Immunolocalization and mRNA expression of bone morphogenetic protein-6 in human clear cell renal carcinoma.

Authors:  Nikolina Basic-Jukic; Margareta Radic-Antolic; Tvrtko Hudolin; Marijana Coric; Renata Zadro; Josip Pasini; Zeljko Kastelan; Petar Kes
Journal:  Kidney Blood Press Res       Date:  2009-12-17       Impact factor: 2.687

10.  Bone morphogenetic protein-2 antagonizes renal interstitial fibrosis by promoting catabolism of type I transforming growth factor-beta receptors.

Authors:  Yu-Lin Yang; Yi-Shiuan Liu; Lea-Yea Chuang; Jinn-Yuh Guh; Tao-Chen Lee; Tung-Nan Liao; Min-Yuan Hung; Tai-An Chiang
Journal:  Endocrinology       Date:  2008-10-01       Impact factor: 4.736

View more
  1 in total

1.  Therapeutic role of uterine-derived stem cells in acute kidney injury.

Authors:  Ramanaiah Mamillapalli; SiHyun Cho; Levent Mutlu; Hugh S Taylor
Journal:  Stem Cell Res Ther       Date:  2022-03-12       Impact factor: 6.832

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.